1. Differentially expressed gene profile and relevant pathways of the traditional Chinese medicine cinobufotalin on MCF‑7 breast cancer cells
    Jie Li et al, 2019, Molecular Medicine Reports CrossRef
  2. Novel Aurora Kinase Inhibitor-Based Combination Therapies for PTCL
    Pavan Tenneti et al, 2019, Peripheral T-cell Lymphomas CrossRef

  3. Identification of Aurora Kinase A as a Biomarker for Prognosis in Obesity Patients with Early Breast Cancer


    Junhan Jiang et al, 2020, OncoTargets and Therapy CrossRef
  4. Deletion of Aurora kinase A prevents the development of polycystic kidney disease in mice
    Ming Shen Tham et al, 2024, Nature Communications CrossRef
  5. Design, synthesis, biological evaluation of 6-(2-amino-1H-benzo[d]imidazole-6-yl)quinazolin-4(3H)-one derivatives as novel anticancer agents with Aurora kinase inhibition
    Chengcheng Fan et al, 2020, European Journal of Medicinal Chemistry CrossRef
  6. Aurora kinase inhibitor VX-680 enhances sensitivity of esophageal squamous cell carcinoma cells to cisplatin chemotherapy
    Junting Kou et al, 2021, Anti-Cancer Drugs CrossRef
  7. Identification of prognostic indicators, diagnostic markers, and possible therapeutic targets among LIM homeobox transcription factors in breast cancer
    Pingping Gao et al, 2022, Cancer Innovation CrossRef
  8. ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
    Iris C. Salaroglio et al, 2019, International Journal of Molecular Sciences CrossRef
  9. Transcriptome Profile Analysis of Triple-Negative Breast Cancer Cells in Response to a Novel Cytostatic Tetrahydroisoquinoline Compared to Paclitaxel
    Madhavi Gangapuram et al, 2021, International Journal of Molecular Sciences CrossRef
  10. Functional analysis of Cullin 3 E3 ligases in tumorigenesis
    Ji Cheng et al, 2018, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef